Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Post COVID-19 ConditionPost-COVID-19 SyndromePost-COVID SyndromeCOVID-19FatigueFatigue Syndrome, Chronic
Interventions
DEVICE

Monoplace Hyperbaric Chamber (Class III medical device).

"40 hyperbaric oxygen therapy (HBOT) treatments (90 minute exposures at 2 atmospheres (ATM) per treatment), scheduled daily from Monday to Friday (i.e., 5 treatments per week) until treatments are completed (approximately 8 weeks). Treatments will be delivered in a medical grade, Health Canada-approved monoplace hyperbaric chamber and overseen by specialist hyperbaric physicians and a Certified Hyperbaric Technologist.~Device is being used in manner consistent with approved usage in Canada."

Trial Locations (1)

M4N3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER